Most clinical trials use between 300 and 1,200 mg of boswellia extract per day, depending on the condition being treated and the potency of the extract. That range matters because not all boswellia supplements are created equal. A high-potency extract standardized to 30% AKBA (the most active compound) can work at just 100 mg per day, while a standard extract with only 2% AKBA may need 900 mg or more to produce similar effects.
Standard Extract Dosages by Use
The most common boswellia supplements contain 60% to 70% total boswellic acids, the group of compounds responsible for the extract’s anti-inflammatory activity. Within that group, one compound called AKBA appears to be the most potent. Standard extracts typically contain only about 2% AKBA, which is why higher total doses are needed.
For joint pain and osteoarthritis, the well-studied dose is 333 mg taken three times daily, totaling roughly 1,000 mg per day. For inflammatory bowel conditions like ulcerative colitis, clinical trials have used 900 mg per day split into three doses of 300 mg. The same three-times-daily pattern shows up in asthma research, where 300 mg three times a day (900 mg total) was used in a six-week trial of patients with persistent bronchial asthma.
The general dosing range across conditions is 300 to 500 mg taken two or three times per day, which puts the daily total somewhere between 600 and 1,500 mg for standard-potency extracts.
High-Potency Extracts Need Much Lower Doses
Newer patented formulations concentrate AKBA to 20% or 30%, dramatically reducing the dose needed. AprèsFlex (also sold under the name Aflapin), which contains at least 20% AKBA, has shown joint pain benefits at just 100 mg per day in multiple trials. An earlier version called 5-Loxin, standardized to 30% AKBA, was tested at both 100 mg and 250 mg per day.
If your supplement label lists one of these branded ingredients, follow the dose on the product rather than applying the 900 to 1,000 mg guideline meant for standard extracts. Taking 1,000 mg of a 30% AKBA extract would be a very different amount of active compound than 1,000 mg of a 2% AKBA extract.
How to Read Your Supplement Label
Check for two things: the total milligrams per capsule and the standardization percentage. A label might say “500 mg Boswellia serrata extract, standardized to 65% boswellic acids.” That tells you the potency is in the standard range, and you’d likely need two to three capsules per day to reach typical clinical doses. If it says “100 mg, standardized to 30% AKBA,” that’s a high-potency extract designed for a single daily dose.
Some products use the whole gum resin rather than a standardized extract. Resin preparations have been used in trials for ulcerative colitis at 350 mg three times a day, but the concentration of active compounds is less predictable than in standardized extracts.
Split Doses or Take It All at Once?
Nearly every clinical trial using standard-potency boswellia split the daily dose into two or three servings throughout the day. The typical pattern is one dose with each meal. This likely helps maintain steadier levels of boswellic acids in the body, since these compounds are fat-soluble and absorb better with food.
The one exception is high-potency extracts like AprèsFlex, which have been studied as a single 100 mg daily dose. If you’re using a standard extract, dividing your total into two or three portions taken with meals is the approach best supported by research.
How Quickly It Works
Boswellia is not an overnight fix, but it works faster than many people expect from a supplement. In osteoarthritis trials, some participants reported meaningful pain relief within five days of starting supplementation. A study using an extract standardized to 30% AKBA found improvements in joint function within seven days.
For muscle soreness and exercise recovery, a recent study gave recreationally active men a boswellia extract for six days before a bout of downhill running, then continued for three days after. Those taking boswellia reported less soreness and less knee pain during the recovery period, and their leg strength returned to baseline faster than the placebo group. Most joint and inflammation studies run for four to six weeks, with benefits generally building over the first month.
Upper Limits and Safety
Doses up to 1,000 mg per day have been used safely in clinical trials lasting up to six months. Short-term use at 2,400 mg per day (for up to one month) has also been reported without significant safety concerns, according to the National Center for Complementary and Integrative Health.
Side effects at typical doses are uncommon and usually mild, mostly limited to digestive discomfort like nausea or acid reflux.
Potential Drug Interactions
Boswellia can affect how your liver processes certain medications. Lab studies show it inhibits several of the enzyme systems responsible for breaking down drugs, particularly CYP2C9 and CYP3A4. These enzymes metabolize a wide range of common medications, including some blood thinners, anti-inflammatory drugs, statins, and certain antidepressants. If you take prescription medications, this is worth discussing with a pharmacist, especially at doses above 500 mg per day.
Quick Reference by Condition
- Joint pain and osteoarthritis: 300 to 500 mg, two to three times daily (standard extract), or 100 mg once daily (high-AKBA extract like AprèsFlex)
- Inflammatory bowel conditions: 300 to 400 mg, three times daily
- Asthma support: 300 mg, three times daily (standard extract), or 500 mg daily (specialized formulation like Casperome)
- General anti-inflammatory use: 300 to 500 mg, two to three times daily with meals